MCC
LLY icon

Maiden Cove Capital’s Eli Lilly LLY Stock Holding History

Maiden Cove Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.11M Sell
1,439
-24
-2% -$19.9K 1.7% 13
2024
Q3 		$1.3M Buy
+1,463
New +$1.32M 2.02% 8

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Maiden Cove Capital's LLY Position: Q4 2024 in Review

Maiden Cove Capital reduced its Eli Lilly (LLY) stake by 1.6% in Q4 2024, selling an estimated $19.9K and leaving 1,439 shares worth $1.11M. The position accounts for 1.7% of the portfolio, ranked #13.

Maiden Cove Capital first reported a position in LLY in Q3 2024 and has held it in 2 quarters since. The position peaked at $1.3M in Q3 2024. 3,913 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Maiden Cove Capital held 1,439 shares of Eli Lilly worth $1.11M as of Q4 2024.
  • Maiden Cove Capital sold 24 Eli Lilly shares in Q4 2024, an estimated $19.9K.
  • Eli Lilly made up 1.7% of Maiden Cove Capital's portfolio in Q4 2024, its #13 holding.
  • Maiden Cove Capital first reported a position in Eli Lilly in Q3 2024 and has held it in 2 quarters since.
  • Maiden Cove Capital's Eli Lilly position peaked at $1.3M in Q3 2024.
  • 3,913 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Maiden Cove Capital's 13F filing for Q4 2024, filed 16 Jan 2025.